ES2136091T3 - Inhibidores de catepsina g y elastasa para prevenir la degradacion del tejido conectivo. - Google Patents

Inhibidores de catepsina g y elastasa para prevenir la degradacion del tejido conectivo.

Info

Publication number
ES2136091T3
ES2136091T3 ES92914209T ES92914209T ES2136091T3 ES 2136091 T3 ES2136091 T3 ES 2136091T3 ES 92914209 T ES92914209 T ES 92914209T ES 92914209 T ES92914209 T ES 92914209T ES 2136091 T3 ES2136091 T3 ES 2136091T3
Authority
ES
Spain
Prior art keywords
connective tissue
catepsin
prevent degradation
elastase inhibitors
elastase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92914209T
Other languages
English (en)
Inventor
Michael R Angelastro
Philippe Bey
Niall S Doherty
Michael J Janusz
Shujaath Mehdi
Norton P Peet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2136091T3 publication Critical patent/ES2136091T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Vehicle Body Suspensions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

NUEVOS COMPUESTOS, QUE SON INHIBIDORES QUIMICAMENTE ENLAZADOS DE LAS PROTEASAS ELASTASA Y CATHEPSIN G, EVITAN LA DEGRADACION DE TEJIDOS CONECTIVA, ASOCIADA CON ENFERMEDAD INFLAMATORIA INDUCIDA POR NEUTROFILOS.
ES92914209T 1991-05-23 1992-04-21 Inhibidores de catepsina g y elastasa para prevenir la degradacion del tejido conectivo. Expired - Lifetime ES2136091T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70449991A 1991-05-23 1991-05-23

Publications (1)

Publication Number Publication Date
ES2136091T3 true ES2136091T3 (es) 1999-11-16

Family

ID=24829789

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92914209T Expired - Lifetime ES2136091T3 (es) 1991-05-23 1992-04-21 Inhibidores de catepsina g y elastasa para prevenir la degradacion del tejido conectivo.

Country Status (17)

Country Link
US (1) US5510333A (es)
EP (1) EP0587799B1 (es)
JP (1) JP3442075B2 (es)
AT (1) ATE181925T1 (es)
AU (1) AU655301B2 (es)
DE (1) DE69229552T2 (es)
DK (1) DK0587799T3 (es)
ES (1) ES2136091T3 (es)
FI (1) FI935172A0 (es)
GR (1) GR3031005T3 (es)
HU (1) HU217612B (es)
IL (1) IL101925A (es)
NO (1) NO934218L (es)
NZ (1) NZ242807A (es)
PT (1) PT100517B (es)
WO (1) WO1992020357A1 (es)
ZA (1) ZA923602B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
DE69332654T2 (de) * 1992-04-10 2003-09-25 Abbott Laboratories, Abbott Park Fragmente eines oberflächenaktiven lungenproteins
CA2137832C (en) * 1992-06-12 2000-09-26 Dennis J. Hoover Inhibitors of angiotensin i chymase(s) including human heart chymase
DK0763055T3 (da) * 1994-06-02 2000-05-08 Merrell Pharma Inc Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf
ES2161293T3 (es) * 1994-06-02 2001-12-01 Merrell Pharma Inc Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5693515A (en) * 1995-04-28 1997-12-02 Arris Pharmaceutical Corporation Metal complexed serine protease inhibitors
DE19543750C2 (de) * 1995-11-24 1997-10-23 Crinos Industria Farmaco Cathepsin G inhibierende Aptamere
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
DK0912601T4 (da) * 1996-04-22 2009-03-09 Massachusetts Inst Technology Suppression af immunrespons ved inhibering af cathepsin S
JP2002047256A (ja) * 2000-07-26 2002-02-12 Kanegafuchi Chem Ind Co Ltd α−アミノ−α´，α´，α´−トリハロケトン誘導体、α−アミノ−α´，α´，α´−トリハロアルコ−ル誘導体、及び、α−ヒドロキシ−β−アミノカルボン酸誘導体の製造法
WO2008054144A1 (en) * 2006-11-03 2008-05-08 Amorepacific Corporation Skin external composition containing cathepsin g inhibitors for preventing skin aging and the screening method for development of antiaging materials
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
WO2021053058A1 (en) 2019-09-17 2021-03-25 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
LT4106757T (lt) 2020-04-16 2023-11-10 Mereo Biopharma 4 Limited Neutrofilų elastazės inhibitoriaus alvelestato panaudojimas kvėpavimo sistemos ligų, nulemtų alfa-1 antitripsino nepakankamumo, gydymui
IL298324A (en) 2020-06-10 2023-01-01 Aligos Therapeutics Inc Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
CA3224494A1 (en) 2021-07-09 2023-01-12 Koen Vandyck Anti-viral compounds
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
JP2024540952A (ja) 2021-10-20 2024-11-06 メレオ バイオファーマ ４ リミテッド 線維化の治療における使用のための好中球エラスターゼ阻害剤
WO2024254398A2 (en) * 2023-06-07 2024-12-12 Redd Pharmaceuticals, Inc. Modulation of neutrophil activation and neutrophil extracellular trap (net) formation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230275A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Elastaseinhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
EP0204571B1 (en) * 1985-06-07 1992-01-22 Ici Americas Inc. Selected difluoro derivatives
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity
EP0307662A3 (en) * 1987-08-24 1990-07-25 Kabushiki Kaisha Vitamin Kenkyusyo Enkephalin analogs
EP0356595A1 (en) * 1988-09-01 1990-03-07 Merrell Dow Pharmaceuticals Inc. Novel peptidase inhibitors
ZA897515B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
CA2021660A1 (en) * 1989-07-26 1991-01-27 Philippe Bey Peptidase inhibitors
DE3938971A1 (de) * 1989-11-24 1991-05-29 Biotechnolog Forschung Gmbh Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat

Also Published As

Publication number Publication date
FI935172L (fi) 1993-11-22
GR3031005T3 (en) 1999-12-31
US5510333A (en) 1996-04-23
NO934218D0 (no) 1993-11-22
HU217612B (hu) 2000-03-28
JP3442075B2 (ja) 2003-09-02
IL101925A0 (en) 1992-12-30
EP0587799A4 (en) 1995-06-14
HU9303314D0 (en) 1994-03-28
HUT65140A (en) 1994-04-28
ZA923602B (en) 1993-02-24
NZ242807A (en) 1994-07-26
IL101925A (en) 1996-03-31
WO1992020357A1 (en) 1992-11-26
DE69229552T2 (de) 1999-12-23
AU2184192A (en) 1992-12-30
FI935172A7 (fi) 1993-11-22
PT100517A (pt) 1993-09-30
NO934218L (no) 1993-11-22
JPH06508355A (ja) 1994-09-22
DE69229552D1 (de) 1999-08-12
ATE181925T1 (de) 1999-07-15
AU655301B2 (en) 1994-12-15
PT100517B (pt) 1999-06-30
FI935172A0 (fi) 1993-11-22
EP0587799B1 (en) 1999-07-07
EP0587799A1 (en) 1994-03-23
DK0587799T3 (da) 1999-11-22

Similar Documents

Publication Publication Date Title
NO934218D0 (no) Inhibitorer av cathepsin G og elastase for forhindring avbindevevsnedbrytning
DE69517196D1 (de) Inhibitoren der menschlichen neutrophilenelastase
DE58905458D1 (de) Endoskop, insbesondere Arthroskop.
ES2191286T3 (es) Moleculas pequeñas, utiles en el tratamiento de enfermedades inflamatorias.
BR0215405A (pt) Composições e processos de uso de collajolie
EA200300050A1 (ru) Гликопептидфосфонатные производные
ES2100943T3 (es) Derivado de bencenosulfonamida.
ES2195970T3 (es) L-ribavirina y usos de la misma.
ES2131973T3 (es) Empleo de 2-amino-4-(4-fluorobencilamino)-1-etoxicarbonilaminobencenos para la profilaxis y el tratamiento de las secuelas de la disminucion aguda y cronica del riego sanguineo cerebral, asi como de afecciones neurodegenerativas.
NO994877L (no) Kalsilytiske forbindelser
DE69107158D1 (de) Gesockelte Hochdruckentladungslampe.
EA200401341A1 (ru) Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания
DE59409806D1 (de) Doppelkolbenpumpe für medizinische Anwendungen
ES2151168T3 (es) N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
DK0804465T3 (da) Nye elastaseinhibitorer
ES2142490T3 (es) Ciclopeptolidos.
AR021241A1 (es) Inhibidores de proteasas
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
DK1073447T3 (da) N1-modificerede glycopeptider
ES2182987T3 (es) Utilizacion de derivados de pirrolidina para el tratamiento del alcoholismo.
IT8919735A0 (it) Procedimento per la riduzione del cod da reflui industriali o urbani.
PT666755E (pt) Inibicao da infeccao pelo vih
CA2109516A1 (en) Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
EA200200750A1 (ru) Новое терапевтическое применение еноксапарина

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 587799

Country of ref document: ES